Fibrodysplasia Ossificans Progressiva Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Condition: Fibrodysplasia Ossificans ProgressivaIntervention: Drug: PalovaroteneSponsor: Clementia Pharmaceuticals Inc.Not yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2015 Category: Research Source Type: clinical trials
